Cerebroprotein hydrolysate oral solution

Cerebroprotein hydrolysate oral liquid is a peptide neurotrophic drug unique to the brain. It can act on the central nervous system in various ways, regulate and improve neuronal metabolism, promote synapse formation, induce neuronal differentiation, and further protect nerve cells from various ischemic and neurotoxin damage. Cerebroprotein hydrolysate oral liquid can pass through the blood-brain barrier. It promotes the synthesis of proteins in the brain, affects the respiratory chain, has the ability to protect against hypoxia, and improves energy metabolism in the brain. It stimulates adenylate cyclase and catalyzes other hormone systems. It provides neurotransmitters, peptide hormones, and coenzyme precursors.

The main ingredient of this product is the product of healthy pig brain defatted with acetone and hydrolyzed with enzymes.

This product is a colorless or light yellow clear liquid.

It is used for diseases such as congenital brain dysplasia, central nervous system infection, senile dementia, sequelae of craniocerebral trauma, and sequelae of cerebrovascular injury.

Oral administration: 50-100 mg each time, 3 times a day.

Allergic reactions such as skin itching and rash may occur.

1. Patients who are allergic to Cerebroprotein Hydrolysate Oral Liquid are prohibited from using this product. 2. Patients with epileptic seizure disorder are prohibited from using this product. 3. Patients with severe renal insufficiency are prohibited from using this product.

Precautions for children: This product has not been tested and there is no reliable reference. Precautions for pregnancy and lactation: Not clear. Precautions for the elderly: This product has not been tested and there is no reliable reference.

Co-treatment with antidepressants may result in adverse interactions, leading to inappropriate mental stress. In this case, it is recommended to reduce the dose of the antidepressant.

Seal and store in a cool place (not exceeding 20℃)

10ml:50mg

Tentatively 24 months.

Jilin Wantong Pharmaceutical Group Meihe Pharmaceutical Co., Ltd.

• Founded in:

  2001-10-18

• Address:

  No. 666, Wantong Road, Meihekou City, Jilin Province

• Tax NO.:

  91220501723125157E

• Registered Funds:

  66 million yuan

• Email:

  Log in to view